2001
DOI: 10.1186/1471-230x-1-10
|View full text |Cite
|
Sign up to set email alerts
|

Ileal mucosal bile acid absorption is increased in Cftr knockout mice

Abstract: BackgroundExcessive loss of bile acids in stool has been reported in patients with cystic fibrosis. Some data suggest that a defect in mucosal bile acid transport may be the mechanism of bile acid malabsorption in these individuals. However, the molecular basis of this defect is unknown. This study examines the expression of the ileal bile acid transporter protein (IBAT) and rates of diffusional (sodium independent) and active (sodium dependent) uptake of the radiolabeled bile acid taurocholate in mice with ta… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
1

Year Published

2002
2002
2019
2019

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 9 publications
(7 citation statements)
references
References 40 publications
0
6
1
Order By: Relevance
“…Bile acid malabsorption has also been reported in a SeHCAT retention analysis of CF patients (O'Brien et al 1993), although an in-vivo perfusion study of human ileum failed to detect any difference in taurocholate and glycocholate uptake between control and CF subjects (Thompson & Davidson 1988). The only other study to use transgenic CF mice to investigate ileal bile acid re-absorption in CF found that, in contrast to the results presented here, taurocholic acid uptake was enhanced in an everted sleeve preparation of CF ileum (Stelzner et al 2001). However, this group used a knockout mouse in which no CFTR is produced, while we have used mice with the ¢F508 mutation where aberrant CFTR is produced but, due to a trafficking defect, fails to reach its normal location at the luminal membrane of the enterocyte (Riordan 1993).…”
Section: Discussioncontrasting
confidence: 99%
“…Bile acid malabsorption has also been reported in a SeHCAT retention analysis of CF patients (O'Brien et al 1993), although an in-vivo perfusion study of human ileum failed to detect any difference in taurocholate and glycocholate uptake between control and CF subjects (Thompson & Davidson 1988). The only other study to use transgenic CF mice to investigate ileal bile acid re-absorption in CF found that, in contrast to the results presented here, taurocholic acid uptake was enhanced in an everted sleeve preparation of CF ileum (Stelzner et al 2001). However, this group used a knockout mouse in which no CFTR is produced, while we have used mice with the ¢F508 mutation where aberrant CFTR is produced but, due to a trafficking defect, fails to reach its normal location at the luminal membrane of the enterocyte (Riordan 1993).…”
Section: Discussioncontrasting
confidence: 99%
“…BA loss may also result from a primary cell defect in the active absorption of BA in the ileum. In vitro studies using brush border membrane vesicles from CF patients have shown that total ileal BA uptake is diminished [176,177]. Surprisingly, a study of Ileal Biliary Acid Transporter (IBAT) in CFTR knock-out mice shows a BA uptake rate four-fold that of wild-type mice [178].…”
Section: Intraluminal Abnormalitiesmentioning
confidence: 99%
“…Other studies noticed that the inhibition of CFTR did not modify the activity of Na ϩ -dependent glucose transporter 1 (21). Furthermore, ileal bile acid transporter and taurocholate uptake were increased in cftr Ϫ/Ϫ mice (33). Overall, these data emphasize that the defect in intestinal lipid absorption in the present study is not specific and that the expression of proteins involved in other metabolic pathways is not modified.…”
Section: Discussionmentioning
confidence: 46%